This website is intended for healthcare professionals only

Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The Pediatric Dermatology Research Alliance (PeDRA) is helping to build a stronger, more sustainable research workforce by providing funding, mentorship, training and collaborative opportunities for investigators at every career stage. Dr Colleen Cotton discusses the challenges facing pediatric dermatology research and why investing in the next generation is essential to improving care for children with skin diseases.

Pediatric Skin Conditions

An Introduction to Pediatric Skin Conditions

Supported by:
EU Partner
EU Partner
US Partner
Dr Margo Gkini
Mark CompleteCompleted
BookmarkBookmarked
Coverage from: BAD 2026
Maria-Angeliki Gkini

Dr Maria-Angeliki Gkini explores the growing role of psychodermatology in supporting patients’ wider needs, alongside emerging technologies and approaches that could shape the future management of psoriatic disease.

Collection of 3
Join us to learn more about the latest data, expert insights and key clinical takeaways from across the congress, and what they could mean for your clinical practice.
Mark CompleteCompleted
BookmarkBookmarked

Meet the dermatologists redefining the future of practice, research, and technology Meet the innovators shaping the future of dermatology The touchDERMATOLOGY Future Leaders 2026 have been nominated and selected to recognize the rising stars shaping the future of across the field ...

Mark CompleteCompleted
BookmarkBookmarked

We are delighted to announce Dr Thy N. Huynh as a touchDERMATOLOGY Future Leader 2026, selected for her work helping to expand access to specialist care and clinical trials for children. We are delighted to welcome Dr Thy N. Huynh as ...

Mark CompleteCompleted
BookmarkBookmarked

The Pediatric Dermatology Research Alliance (PeDRA) is helping to build a stronger, more sustainable research workforce by providing funding, mentorship, training and collaborative opportunities for investigators at every career stage. Dr Colleen Cotton discusses the challenges facing pediatric dermatology research and why investing in the next generation is essential to improving care for children with skin diseases.

Mark CompleteCompleted
BookmarkBookmarked

The FDA has cleared the first company-sponsored clinical study in peeling skin syndrome, allowing a phase 2 trial of QRX003 to begin later this year. The investigational topical therapy could represent an important step forward for a rare inherited skin disorder with no approved treatment.

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: BAD 2026
Viktoria Eleftheriadou

The treatment landscape for vitiligo is evolving, with recent therapeutic advances, potential oral treatments, combination strategies and new consensus efforts helping to shape future care. In this expert interview, Prof. Viktoria Eleftheriadou discusses key takeaways from her BAD Annual Meeting session, including emerging systemic therapies, approaches to improving repigmentation outcomes and the importance of defining vitiligo severity beyond body surface area alone.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our LEADderm mini-series exploring non-clinical skills that can help you thrive in your ...

Coverage from: AAD 2026

Phase 2 findings support weight-based dosing and sustained efficacy through 52 weeks, with no unexpected adverse events in children aged 2-11 with moderate-to-severe atopic dermatitis. [touchplayvideo video_id="516mi7fd42"] TouchDERMATOLOGY coverage from AAD 2026: With four presentations exploring the use of nemolizumab ...

PeDRA
Mark CompleteCompleted
BookmarkBookmarked

Returning this October, the 2026 PeDRA Annual Conference will bring together clinicians, researchers, trainees, patients, advocates, and industry partners to share ideas, build collaborations, and support progress in pediatric dermatology research. This Q&A offers a preview of the meeting’s theme, format, and opportunities for attendees across career stages.

8 defining developments in dermatology in 2025
Mark CompleteCompleted
BookmarkBookmarked
Raj Chovatiya, Tiago Torres, Yi-Kui Xiang

As 2025 draws to a close, it is clear that the past year has brought notable shifts across dermatology. To reflect on the developments that stood out most, members of our editorial board and recipients of our 2025 Future Leaders in Dermatology award share their perspectives, drawing on experience across subspecialties, regions and stages of career.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.

atopic eczema
Mark CompleteCompleted
BookmarkBookmarked

The EADV 2025 Congress in Paris showcased the latest research and treatment advances in dermatology. To highlight the most important updates in both paediatric and adult atopic dermatitis, we spoke with Professor Carsten Flohr, a leading expert from London, UK.

Epidermal differentiation disorders
Mark CompleteCompleted
BookmarkBookmarked
Coverage from: EADV 2025
Antoni Gostyński

Epidermal differentiation disorders (EDDs) are a group of inherited skin conditions caused by disruptions in epidermal development. In recent years, the field has seen major progress, with significant updates to nomenclature, classification and their management. To gain deeper insight into these developments, we spoke with Dr Antoni Gostyński (Maastricht, Netherlands), who co-chaired the EADV 2025 session ‘Epidermal Differentiation Disorders (EDDs) Group: From Genes to Clinics – The Truth About EDDs in 90 Minutes’.

childhood food allergies
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we speak with leading paediatric allergist Prof. Helen Brough to explore the key factors behind why some children develop allergies to foods such as peanuts, and what we can do to help prevent them. We also examine the latest developments in managing food allergies and the innovations on the horizon that could transform how we treat them.

15 minutes
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Expert insights on referral, risk stratification and treatment for patients with infantile haemangiomas.

Endorsed by the Pediatric Dermatology Research Alliance (PeDRA).

touchDERMATOLOGY Future Leaders 2025
Mark CompleteCompleted
BookmarkBookmarked

This year, we are celebrating our inaugural touchDERMATOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform dermatology in the years to come. Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of dermatology. We had the pleasure of learning about their unique career journeys, motivations, and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in dermatology today, along with their hopes for the future of the field. Congratulations to all our touchDERMATOLOGY Future Leaders, and thank you for sharing your stories, insights and ambitions with us.

Load More...
Close Popup